Vnitr Lek 2017, 63(6):386 | DOI: 10.36290/vnl.2017.080

Testikulární lymfomy - editorial

Vít Procházka
Hemato-onkologická klinika LF UP a FN Olomouc

Received: June 12, 2017; Published: June 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Procházka V. Testikulární lymfomy - editorial. Vnitr Lek. 2017;63(6):386. doi: 10.36290/vnl.2017.080.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Trněný M, Klener jr. P, Pytlík R. Maligní lymfomy - minulost, současnost a budoucnost. Klin onkol 2015; 28(Suppl 3): 55-63. Dostupné z DOI: <http://doi:10.14735/amko20153S55>. Go to original source... Go to PubMed...
    2. Chapuy B, Roemer MG, Stewart C et al. Targetable genetic features of primary testicular and primary central nervous system lymphomas. Blood 2016; 127(7): 869-881. Dostupné z DOI: <http://doi:10.1182/blood-2015-10-673236>. Go to original source... Go to PubMed...
    3. Nayak L, Iwamoto FM, LaCasce A. PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma. Blood 2017; 129(23): 3071-3073. Dostupné z DOI: <http://doi:10.1182/blood-2017-01-764209>. Go to original source... Go to PubMed...
    4. Motyčková M, Vosáhlová V, Belada D et al: Primární testikulární lymfomy. Vnitř Lék 2017; 63(5): 415-422. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.